Table 4 Univariate and multivariate Cox proportional hazards model analysis for disease-free survival

Age

0.050

  ≤ 57

Reference

 >57

1.000–1.751

Gender

0.021

0.008

 Male

Reference

Reference

 Female

0.522–0.948

0.491–0.898

Smoking history

0.270

 Y

Reference

 N

0.649–1.128

Stage

<0.001

0.001

 I-II

Reference

Reference

 IIIA

3.132–5.367

1.433–3.909

Pathological tumor

Classification (pT)

0.001

0.577

 pT1–2

Reference

Reference

 pT3–4

1.234–2.415

0.746–1.694

Pathological lymph node

stage (pN)

<0.001

<0.001

 pN0

Reference

Reference

 pN1–2

3.368–6.032

3.122–8.575

Histological type

0.248

 Squamous cell carcinoma

Reference

 Adenocarcinoma

0.677–1.203

 Large cell carcinoma

0.815–2.122

Surgery type

<0.001

0.082

 Lobectomy

Reference

Reference

 Pneumonectomy

2.166–3.814

0.915–2.118

 Other

1.341–3.519

0.472–1.449

Adjuvant chemotherapy

<0.001

<0.001

 Y

Reference

Reference

 N

1.960–3.462

1.723–5.397

GLU (mmol/L)

0.357

  ≤ 5.75

Reference

 >5.75

0.654–1.166

TC (mmol/L)

0.779

  ≤ 4.59

Reference

 >4.59

0.733–1.263

TG (mmol/L)

<0.001

0.002

  ≤ 1.21

Reference

Reference

 >1.21

1.444–2.436

1.177–2.025

HDL-C (mmol/L)

<0.001

<0.001

  ≤ 1.26

Reference

Reference

 >1.26

0.372–0.661

0.444–0.793

LDL-C (mmol/L)

0.027

0.565

  ≤ 2.26

Reference

Reference

 >2.26

1.038–1.845

0.810–1.470

ApoA1(g/L)

0.390

  ≤ 1.21

Reference

 >1.21

0.682–1.161

ApoB(g/L)

0.126

  ≤ 1.15

Reference

 >1.15

0.449–1.103

Lpa (mg/L)

0.344

  ≤ 53

Reference

 >53

0.582–1.207